You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股醫美概念爆發:瑞麗醫美漲超50%,復星醫藥漲超20%,均創歷史新高
格隆匯 05-03 15:06
格隆匯5月3日丨近期受資金持續追捧的醫美概念股繼續活躍,港股市場醫美概念股今日再度集體爆發,午後漲幅進一步擴大。瑞麗醫美一度漲超50%再創歷史新高價1.02港元,自4月14日上漲至今累漲超210%;復星醫藥(2196.HK)一度漲超20%超歷史新高價,自4月初以來至今累漲近80%;上個交易日創歷史新高的復鋭醫療科技(1696.HK)今日一度漲超16%欲再創歷史新高,自4月初以來累漲近200%。有機構指出,顏值經濟推動醫美市場高景氣,醫美接受度進一步提升,2019年中國醫美市場規模超1500億元,增速領先全球,但當前我國醫美滲透率相較於大部分發達國家仍較低,預計在滲透率持續提高下醫美市場將保持高增,預計2023年有望超3000億元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account